CN101757033A - Eyesight-improving ointment - Google Patents
Eyesight-improving ointment Download PDFInfo
- Publication number
- CN101757033A CN101757033A CN200810158902A CN200810158902A CN101757033A CN 101757033 A CN101757033 A CN 101757033A CN 200810158902 A CN200810158902 A CN 200810158902A CN 200810158902 A CN200810158902 A CN 200810158902A CN 101757033 A CN101757033 A CN 101757033A
- Authority
- CN
- China
- Prior art keywords
- parts
- eyesight
- ointment
- calcined
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of medicines and discloses a traditional Chinese medicine prescription of an eyesight-improving ointment. The eyesight-improving ointment is prepared from prepared calamine, calcined coral, amber, borneol, musk, pearl, zinnober, calcined borax and bear gall based on the different characteristics and different proportionings of each traditional Chinese medicine. The prescription is exclusive, has obvious effects on treating sore red swollen eyes, epiphora induced by wind and the like, and has the advantages of simple and convenient processing and preparation and convenient use.
Description
Affiliated technical field:
The present invention relates to Chinese medicine preparations such as a kind of treatment conjunctival congestion and swelling pain, acute bacterial conjunctivitis, belong to Chinese medicine medicament for the eyes field.
Background technology
The external oculopathy ophthalmic is commonly encountered diseases, the frequently-occurring disease of ophthalmology, all has popular throughout the year.Especially conjunctivitis because of infect, irritated, conjunctival congestion that wound causes, ooze out, changes such as papillary hypertrophy and folliculus formation.Its reason can be divided into: 1. exogenous.Because conjunctiva exposes, be subject to the stimulation of extraneous various microorganism, travel fatigue, physics and chemistry poisonous substance etc. and produce inflammation.2. endogenous.Capable or lymph infects conjunctiva to pathogenic bacterium by blood, or to the infectious agent generation anaphylaxis of whole body elsewhere.Inflammation also can be by adjacent tissue's direct extension.Conjunctivitis is divided into bacillary, viral, chlamydia, mycotic, allergy etc. according to its cause of disease.Its common clinical manifestation is the burst conjunctival congestion, burn feeling, itch, secretions is many, general vision is unaffected, check and find the eyelid redness, palpebral conjunctiva hyperemia, nipple follicle hypertrophy, the hyperemia of bulbar conjunctiva peripherality, edema and subconjunctival hemorrhage sometimes, secretions is arranged in the conjunctival sac, determine that source of disease need make the secretions smear and carry out antibacterial and cytolgical examination.Treatment should be at cause of disease local application.Mostly be Western medicine at present at conjunctival congestion and swelling pain, conjunctivitis, Chinese medicine does not almost have, and now looks into no eye ointment prescription of the present invention.
Summary of the invention:
Big in order to overcome dosage, oral drugs are difficult to the deficiency by blood-eye barrier, invent a kind of gel for eye use, the ophthalmology topical, not only solved eye drop and easily diluted by tear, the defective that the ophthalmic time of staying is short, and use amount is few, improve the bioavailability of effective ingredient, increase curative effect and drug safety.
Technical scheme of the present invention is:
Calamina(processed) 50-70 part is forged Corallium Japonicum Kishinouye 3-6 part, succinum 3-6 part, Borneolum Syntheticum 16-20 part, Moschus 1-3 part, Margarita 1-3 part, Cinnabaris 2-4 part, Borax(calcined) 5-7 part, Fel Ursi 6-8 part.
Above Chinese herbal medicine ground jointly be smalls, add water and make eye ointment by traditional approach.A little is put in the face with eye ointment.
Most preferred embodiment:
60 parts of Calamina(processed) are forged 4.5 parts on Corallium Japonicum Kishinouye, 4.5 parts of succinums, 18 parts of Borneolum Syntheticums, 1.2 parts in Moschus, 1.2 parts of Margaritas, 3 parts in Cinnabaris, 6 parts of Borax(calcined), 7.5 parts of Fel Ursis.
Above Chinese herbal medicine ground jointly be smalls, add water and make eye ointment by traditional approach.A little is put in the face with eye ointment.
Claims (2)
1. an eyesight-improving ointment is characterized in that being made up of by weight following Chinese medicinal components: Calamina(processed) 50-70 part, forging Corallium Japonicum Kishinouye 3-6 part, succinum 3-6 part, Borneolum Syntheticum 16-20 part, Moschus 1-3 part, Margarita 1-3 part, Cinnabaris 2-4 part, Borax(calcined) 5-7 part, Fel Ursi 6-8 part.
2. a kind of eyesight-improving ointment according to claim 1 is characterized in that: 60 parts of Calamina(processed), forge 4.5 parts on Corallium Japonicum Kishinouye, 4.5 parts of succinums, 18 parts of Borneolum Syntheticums, 1.2 parts in Moschus, 1.2 parts of Margaritas, 3 parts in Cinnabaris, 6 parts of Borax(calcined), 7.5 parts of Fel Ursis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810158902A CN101757033A (en) | 2008-11-21 | 2008-11-21 | Eyesight-improving ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810158902A CN101757033A (en) | 2008-11-21 | 2008-11-21 | Eyesight-improving ointment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101757033A true CN101757033A (en) | 2010-06-30 |
Family
ID=42488514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810158902A Pending CN101757033A (en) | 2008-11-21 | 2008-11-21 | Eyesight-improving ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101757033A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614252A (en) * | 2012-04-13 | 2012-08-01 | 许凤喜 | Prescription for treating cataract |
| CN103127233A (en) * | 2013-02-27 | 2013-06-05 | 尹梦竹 | Traditional Chinese medicine for treating eye diseases, and its production method |
| CN113827621A (en) * | 2017-12-08 | 2021-12-24 | 河北金牛原大药业科技有限公司 | A Chinese medicinal composition semi-solid preparation for eye use, and its preparation method |
-
2008
- 2008-11-21 CN CN200810158902A patent/CN101757033A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614252A (en) * | 2012-04-13 | 2012-08-01 | 许凤喜 | Prescription for treating cataract |
| CN103127233A (en) * | 2013-02-27 | 2013-06-05 | 尹梦竹 | Traditional Chinese medicine for treating eye diseases, and its production method |
| CN113827621A (en) * | 2017-12-08 | 2021-12-24 | 河北金牛原大药业科技有限公司 | A Chinese medicinal composition semi-solid preparation for eye use, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101716214B (en) | Medical composition containing dandelion extract as well as novel application and preparation method thereof | |
| WO2014031964A1 (en) | Composition for the treatment of migraine headaches | |
| Anselmo-Lima et al. | Invasive fungal rhinosinusitis in immunocompromised patients | |
| CN102362924B (en) | Medicinal composition for treating ophthalmic diseases and preparation method thereof | |
| DE102009003942A1 (en) | Use of deuterium oxide for the treatment of virus-based diseases of the eye | |
| CN1383379A (en) | Method of treatment of seborrheic dermatitis | |
| WO2012092375A1 (en) | Method for treating dry eye | |
| CN101757033A (en) | Eyesight-improving ointment | |
| JP2018503641A (en) | Acne-removing herbal medicine composition and method for producing the same | |
| CN111544390A (en) | Traditional Chinese medicine preparation for treating meibomian gland dysfunction and/or allergic conjunctivitis, ultrasonic atomization and nano-spray preparation and preparation method | |
| US11045503B2 (en) | Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis | |
| JPH05509288A (en) | Topical treatment of blepharitis | |
| CN101884649A (en) | Traditional Chinese medicine for treating oculopathy | |
| CN102525889A (en) | Ornidazole ophthalmic gel and preparation method and application thereof | |
| CN109091584A (en) | A kind of swelling and pain relieving ointment and preparation method thereof | |
| US8658227B2 (en) | Botanical formulation derived from birch bark | |
| CN107596370A (en) | A kind of drug compound preparation and purposes for treating cervical erosion | |
| CN102462768A (en) | Female nursing solution for external use | |
| CN103110734B (en) | Traditional Chinese medicine composition for treating gynecologic inflammation and preparation method thereof | |
| CN101766731B (en) | Tea polyphenol acne resistant external preparation | |
| CN104666420A (en) | A medicine for treating rhinitis | |
| WO2020024246A1 (en) | Ear drops used for tinnitus and with ear health and relief functions | |
| CN107583050A (en) | A kind of pharmaceutical composition and purposes for being used to treat cervicitis | |
| CN103405576B (en) | The eye drop of the ocular disease that a kind for the treatment of is caused by welding high light radiation | |
| CN102614252B (en) | Prescription for treating cataract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100630 |